CAMERON ROBERT WOLFE
PERSONAL DETAILS:
Name: Cameron Robert Wolfe,
MBBS (Hons), MPH, CPDM, A.Mus.A
Office: (Ms Kelly Stanly) +1 919-668-0789
Facsimile: +1 919-684-8902
Email: [email protected]
EDUCATION:
M.B.B.S. (Honours); University of Melbourne, 1995 – 2000
Master of Public Health (Health Policy & Management); 2013
UNC (Chapel Hill), North Carolina
Certificate in Community Preparedness & Disaster Management, CPDM,
UNC (Chapel Hill), North Carolina, 2010
Associate Diploma in Pianoforte: Performance; A.Mus.A, 1994, University of Sydney
Member of Infectious Diseases Society of America 2007 – present
Member of American Society of Transplantation 2012- present
Member of International Society for Heart and Lung Transplantation 2014 - presen
Member of American Society for Blood and Marrow Transplantation 2015 – present
CURRENT & PREVIOUS EMPLOYMENT:
Assistant Professor of Medicine: Division of Infectious Diseases & International Health
Bio-preparedness Director, Duke Preparedness and Response Center,
2009 – to current
Inpatient- Transplant ID Attending Physician: caring for solid organ
transplant recipients, recipients of cardiac support devices, patients with
malignant haematology related infections.
Outpatient- HIV and Transplant Infectious Diseases care;
Outreach HIV medicine - Southern Regional AHEC, Fayetteville, NC
Supervision of Fellows & Medicine residents in training programs;
Faculty, T32 Interdisciplinary Program in Transplant Infectious Disease
Faculty, T32 Interdisciplinary Research Training Program in AIDS;
Faculty, Duke Vaccine and Treatment Evaluation Unit
Medical Adjudication & Advisory panel, Duke BSL3 laboratory.
Infectious Disease liaison to University Student Health & Employee Health
Adjunct Lecturer: School of Public Health, University of North Carolina, Chapel Hill
2011 – to current
Lectures: Infectious Disease outbreaks; Bio-surveillance and bio-vigilance;
Globalisation and impacts on Infectious Disease
Infectious Diseases Fellowship, 2007-2008: Duke University Medical Center
Advanced Training Registrar, 2006-2007: Monash Medical Centre
Inc 6-months accredited microbiology laboratory rotations
Medical Residency, Advanced Registrar, 2001- 2005: St Vincent’s Hospital, Melbourne
CONSULTANT APPOINTMENTS:
Organ Procurement and Transplantation Network / United Network for Organ Sharing
(OPTN/UNOS) - Disease Transmission Advisory Committee; national organization to review
possible cases and consider issues and federal policy related to the transmission of disease and
malignancy through organ transplantation,
o appointed: 2012 – 2014;
o Vice Chair 2014-2016
o Chairman 2016-2019
Chair, OPTN/UNOS Failure Modes Effectiveness Analysis (FMEA) Taskforce– assessing
systems improvements in sharing new donor information with transplant recipient centers.
Infectious Disease Society of America, Influenza Guidelines national working group,
appointed 2013 - ongoing
Chairman, Independent Data Monitoring Committee (IDMC);
Consultant, External scientific and protocol development; GlaxoSmithKline – IV Zanamivir
for the treatment of hospitalized patients with influenza, 2010-present
Infectious Disease Society of America: Standards and Practice Guidelines Committee
member; appointed: 2012 – 2016. Liaison to Influenza and Lyme Disease Guidelines.
UNOS Committee member and NIH Review panel: HOPE Act Work Group 2014, to
implement guidelines regarding safe transplantation of HIV-infected organs in the United
States in accordance with Hope Act, Public Law 113-51, 113th U.S. Congress.
Committee Member, 2016 CDC Special Emphasis Panel: Emerging Infections Program,
CK17-1701
Lead Principal Investigator: Duke Clinical Research Institute – Gilead; GS-US-218-0108 &
218-1502 protocols for GS-5806 treatment of respiratory syncytial virus in hematopoietic
stem cell transplant recipients, awarded July 2014, terminated 2016
External Medical Consultant: GSK, Internal Safety Review Committee, Danirixin Outpatient
Influenza protocol, 2015-2016
Scientific Advisory Board: Invasive Aspergillosis and Rare Molds Virtual Advisory Network,
Astellas Pharma, US, Inc., 2015-2016
Medical Adjudication Panel: Cellerant – Phase II clinical trial investigating use of human
myeloid progenitor cells for prevention of infection during AML induction chemotherapy;
commencing 2014 - 2016.
Chairman, Independent Data Monitoring Committee (IDMC); Alios Biopharma, ALS-8176-
510 Phase 2/2b use of oral ALS-008176 for Respiratory Syncytial Virus infection, 2015-2016
Chairman, Independent Data Monitoring Committee (IDMC); JanssenBiotech,
VX787FLZ2001 and 636323872FLZ2002 Phase 2/3 protocols, treating patients with JNJ-
63623872 in combination with oseltamivir for active infection with influenza, 2015-2016
Independent Safety Monitor: Healthy Older Adult, Phase 2 MF59-Adjuvanted, Monovalent
Inactivated Influenza A/H7N9 Virus Vaccine Trial. Division of Microbiology and Infectious
Diseases (DMID), National Institute of Allergy and Infectious Diseases (NIAID); Appointed
2014 - 2016
OPTN/UNOS Policy Oversight Committee: Appointed General member, 2014 – 2016
Independent Safety Monitor: Pharmacokinetics and Pharmacodynamics of Three Dosing
Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Subjects. Protocol: 15-0049
Division of Microbiology and Infectious Diseases (DMID), National Institute of Allergy and
Infectious Diseases (NIAID); Appointed 2015-2016
ACADEMIC APPOINTMENTS and PARTICIPATION:
Current
Physician Lead, Duke University Health System: Ebola Response Taskforce, 2014 - 2015
Duke University Ebola Travel Exemption Oversight Committee
Co-Chair, Duke Influenza Vaccine Taskforce, 2010-present
Member of Hospital Infection Control Committee (HICC), 2010-present
Previous
Member of SERCEB (Southeast Regional Center for Excellence in Emerging Infections and
Biodefence) conference organizing committee, 2009-2014.
Co-Chair, North Carolina Hospital Influenza Taskforce, 2010-2012
Full board member of Duke Institutional Review Board, 2009-2013
Co-team leader for two Duke Hospital medical relief missions to Haiti, 2009
Duke University Course in Scientific Leadership and Management, 2010-11
AWARDS and SCHOLARSHIPS:
Duke University Hospital Strength, Hope and Caring Award, 2015 (Ebola management team)
North Carolina’s Best Doctors, Dec 2015
Duke University Blue Ribbon Teamwork award, 2014 (Influenza management team)
Duke University Hospital Strength, Hope and Caring Award, 2009 (individual patient care)
Duke University Hospital Fellow’s Teaching award, 2008
Australian Commonwealth John Flynn Scholarship, for work in an Aboriginal
community health network, 1997 – 2000
Rural Australia Medical Undergraduate Scholarship (RAMUS); awarded 2000
Chancellor’s Scholarship (Chemical Engineering); The University of Sydney, 1994
LECTURES & PRESENTATIONS:
International:
Wolfe CR: Lessons Learned from 2009 H1N1, Infectious Diseases Society of America 2010
Annual Meeting, Vancouver, Canada. Speaker, Session # 109, Sat 23rd October
Wolfe CR: Interactive Cases in Transplant, Interactive Panel; ID Week 2013, San Francisco,
Sat 5th, 2013
Wolfe CR, Schaenman, J: Top 10 papers in Transplant Infectious Disease, ID Week 2015,
San Diego, Thurs 8th, 2015
Wolfe CR: (on behalf of B.D.Alexander) Outbreak! Infection Clusters and the Transplant
Center, International Society for Heart and Lung Transplantation, 36th Annual Meeting and
Scientific Sessions; April 29, 2016
Wolfe CR: Donor-derived infections – Primer on Transplantation, ASM Microbe 2016,
Boston, Jun 17th, 2016
University:
Wolfe CR, Permar S, Moe J: Zika, an evolving challenge, Duke Innovation Challenge, Fuqua
School of Business, March 22, 2016
Wolfe CR, Woods C, Bali S, Merson, M: Domestic and International Lessions from Ebola,
Global Health Law and Policy Symposium, Duke University, Durham, NC, Nov 12, 2015
Wolfe CR: Infectious Diseases Complications for Transplant Recipients; Duke University 1st
Annual National Lung Transplant Symposium, August 2015
Wolfe CR: New Issues in Vaccinating Adults; Duke University Internal Medicine Feb, 2015
Wolfe CR: Vector borne illness in North Carolina, North Carolina State University, Student
Health, Dec 9, 2014
Wolfe CR: Hospital and Syndromic Surveillance Systems in Disaster Preparedness; Gillings
School of Public Health UNC-Chapel Hill, Community Preparedness & Disaster Management
Certificate lecture series, 2012-2014
Wolfe CR: Environmental and Public Health Surveillance after major disasters; Gillings
School of Public Health UNC-Chapel Hill, Community Preparedness & Disaster Management
Certificate lecture series, 2013-2014
Wolfe CR, Chen L: Ebola - an African Hot Zone; an American anxiety; Duke Pediatric Grand
Rounds, Oct 2014
Wolfe CR: The Globalization of Infectious Disease; Gillings School of Public Health UNC-
Chapel Hill, SPH-HPM-664, 2013
Wolfe CR: Appropriate use of antibiotics; North Carolina State University, Student Health,
Dec 10, 2013
Wolfe CR, Hollingsworth J, Cheifetz I: Pandemic Influenza: Challenges, Research & Clinical
Controversies; Duke University Grand Rounds, 2011
Wolfe CR: Urologic Care for the HIV patient; Duke University Urology Forum, Feb 2013
Wolfe CR: Challenging bioethics cases in the world of rationed healthcare; Duke University
Bioethics Conference, 2012, February
Wolfe CR, Greenwald IR, Woods C: Global Pandemics – Local Context; Duke University
Winter Forum, 2011, January 10th
Wolfe CR, et al: Cases in Medical Bioethics, Duke-UNC Bioethics Symposium, 2012
National:
Wolfe CR: National Reforms in Reporting of Transplant Donor-Derived Diseases;
Association of Organ Procurement Organizations Tri-Council Conference, Houston, Tx, Feb
3rd, 2016
Wolfe CR: Ebola Virus response –unique issues for an Academic Medical Center;
Association for Professionals in Infection Control, NC Chapter, Annual Conference, Raleigh,
Sept 2015
Wolfe CR: Hospital-based Response Opportunities to Ebola Virus in North Carolina; Ebola
Response: Globally to Locally, NC Communicable Diseases Conference, Raleigh, April, 2015
Wolfe CR: Emerging Infections in Transplantation; Association of Organ Procurement
Organizations Tri-Council Conference, Charleston, SC, Feb 11, 2015
Wolfe CR: Ebola – clinical and emergency preparedness updates , Halifax Regional
Hospital, South Boston, Virginia; Jan 26th, 2015
Wolfe CR: Infectious Disease Assessment in the Organ Donor, and Infectious Diseases in
Transplant; Invited Lectures, The NATCO (Organization for Transplant Professionals)
Annual Meeting, Tempe, AZ, June 2013.
Wolfe CR: Infectious Diseases in Transplantation and Infectious Disease Assessment in the
potential Organ Donor; Invited Lectures, The NATCO (Organization for Transplant
Professionals), Annual Meeting, Tempe, AZ, June 2014
Wolfe CR, Rupprecht C, Abrahamian F, Slate D: Rabies transmission and prevention,
SABoney & Associates, online webcast, June 2013
Wolfe CR: Updates in HIV care; Infectious Diseases Society of America, NC Chapter, 2012
Annual Meeting. Charlotte, Nov 17th, 2012.
Wolfe CR: Transgender health issues and Meds in HIV: New Developments; 30year later:
HIV conference 2012; Southern Regional AHEC, Fayetteville, NC, Nov 2012
Wolfe CR: Viral hepatitis – updates on Risks, Rates and Ravages; Infusion Nurses Society,
Annual Convention, 2011, Louisville, KN, May 23rd
Wolfe CR: HIV – toxicities, transmission and treatment; Infusion Nurses Society, Annual
Convention, Nashville, TN, 2009, May 5th
PUBLICATIONS: RF Chemaly, SL Aitken, CR Wolfe, R Jain, MJ Boeckh: Aerosolized Ribavirin: the most
expensive drug for pneumonia; Transplant Infectious Disease, 18 (3), 2016
Green, Michael; Covington, Shandie; Taranto, Sarah; Wolfe, Cameron; Bell, Walter; Biggins,
Scott W.; Conti, David; DeStefano, G. David; Dominguez, Edward; Ennis, Donna; Gross,
Thomas; Klassen-Fischer, Mary; Kotton, Camille; LaPointe-Rudow, Dianne; Law, Yuk;
Ludrosky, Kristen; Menegus, Marilyn; Morris, Michele I.; Nalesnik, Michael A.; Pavlakis,
Martha; Pruett, Timothy; Sifri, Costi; Kaul, Daniel; Donor-Derived Transmission Events in
2013: A Report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission
Advisory Committee, Transplantation, 2015 Feb;99(2):282-7
Argento C, Wolfe CR, Wahidi M, Shofer S, Mahmood K; Broncho-Mediastinal Fistula
Caused by Endobronchial Aspergilloma , Annals of the American Thoracic Society, 2015
Jan;12(1):91-5
Kaul D, Mehta A, Wolfe CR, Green M, Blumberg E; Ebola Virus Disease: Implications for
Solid Organ Transplantation; American Journal of Transplantation, Dec 15, 2014
Catania.J, Que.L, Govert.J, Hollingsworth.J, Wolfe.CR; High ICU admission rate for 2013-
2014 Influenza is associated with a low rate of vaccination; American Journal of Respiratory
and Critical Care Medicine, Vol. 189, No.4 (2014), pp. 485-487
Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, Moore ZS,
Anderson DJ, Duffy J, Gubareva LV, Sexton DJ, Fry AM, Srinivasan A, Wolfe CR., Cluster
of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital
Ward among Immunocompromised Patients--North Carolina, 2009. Journal of Infectious
Diseases 2011 203: 838-846
Martin S, Hollingsworth C, Norfolk S, Wolfe, C and Hollingsworth J; Reversible cardiac
dysfunction associated with pandemic 2009 influenza A(H1N1) Chest. 2010
May;137(5):1195-7. Chest. 2010 May;137(5):1195-7
Brown-Elliott B, Iakhiaeva E, Griffith D, Woods G, Stout J, Wolfe CR, Turenne C and
Wallace R; In Vitro Activity of Amikacin Against Isolates of Mycobacterium avium complex
with Proposed MIC Breakpoints And Finding of a 16S rRNA Gene Mutation in Treated
Isolates, J Clin Microbiol. 2013 Oct;51(10):3389-94
Gargano L, Wolfe C, et al; Issues in the Development of a Research and Education
Framework for One Health Emerg Infect Dis 2013; Vol 19, Number 3
Biggs H, Chudgar S, Pfeiffer C, Rice K, Zaas A, Wolfe CR; Disseminated Mycobacterium
immunogenum infection presenting with septic shock and skin lesions in a renal transplant
recipient; Transplant Infectious Disease 2012
Martin, S, Hollingsworth C, Norfolk S, Wolfe C and Hollingsworth J; Response: Pandemic
H1N1 and cardiac dysfunction. Chest, 2011.
Lisa M. Gargano, Patrick F. Gallagher, Ashley S. Freeman, J. Glenn Morris, Susan
Temporado Cookson, Ian Greenwald, Paola Lichtenberger, Wilbur K. Milhous, Mildred
Williams-Johnson, Cameron Wolfe, Alexander Isakov, Christopher W. Woods, and James M.
Hughes; Academic Consortia: Untapped Resources for Preparedness, Response, and
Recovery—Examining the Cholera Outbreak in Haiti. Emerg Infect Dis 2011, 17(11) Epub
Oct 2011.
Wolfe CR. Case Report: Treatment of Chronic Osteomyelitis; Clin Infect Dis. 2011 Jun;52
Wolfe, CR and Hicks, C; Darunavir – A clinical review, HIV/AIDS – Research and Palliative
Care, 2009 (1):13-21, DOI 10.2147/HIV.S4842
Taylor SM, Wolfe CR, Dixon TC, Ruch DS, Cox GM; Wound botulism complicating the
internal fixation of a complex radial fracture, J Clin Microbiol. 2010 Feb;48(2):650-3. Epub
2009 Dec 9
Norfolk SG, Hollingsworth CL, Wolfe CR, Govert JA, Que LG, Cheifetz IM, Hollingsworth
JW.; Rescue therapy in adult and pediatric patients with pH1N1 influenza infection: a tertiary
center intensive care unit experience from April to October 2009; Crit Care Med. November
2010, 38(11), pp 2103-2107
Wolfe CR, Greenwald I, Chen L. Pandemic (H1N1) 20009 and oseltamivir resistance in
hematology/oncology patients. Emerg Infect Dis 2010, 16(11) p1808-1811
Wolfe CR; Staying Committed in Haiti; News & Observer; May 29, 2010
POSTER PRESENTATIONS and ABSTRACTS:
CR Wolfe, AR Wilk, CD Sifri, M Morris, A Mehta and D Kaul: Donor-derived
Toxoplasmosis in Solid Organ Transplant 2008-2015: Opportunities for improvement; 2016
American Transplant Congress, Boston, MA, June 12, 2016
AR Wilk, S Taranto, CR Wolfe, M. Nalesnik: Recipient Outcomes in U.S. Cases of Post-
Donation Living Donor Malignancy; 2016 American Transplant Congress, Boston, MA, June
13, 2016
ML Volk, AR Wilk, CR Wolfe, D Kaul: “PHS Increased Risk” label is associated with non-
utilizaqtion of hundreds of organs per year; 2016 American Transplant Congress, Boston,
MA, June 13, 2016
D Kaul, S Tlusty, A Wilk, and C Wolfe: A Decade of Donor-Derived Disease: A Report of
the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC); 2016 American
Transplant Congress, Boston MA, June 12, 2016
J. Schaenman, A Wilk, S Tlusty, M Michaels, CR Wolfe, D Kaul: Donor Derived Disease
Transmission Events in Thoracic Organ Transplantation: Data Reviewed by the OPTN Ad
Hoc Disease Transmission Advisory Committee; International Society for Heath and Lung
Transplantation Annual Meeting, Washington D.C., April, 2016. Abstract 2788
AW Baker, SS Lewis, BD Alexander, P Isaacs, LC Pickett, RJ Wallace Jr, BA Brown-Elliott,
N Strittholt, KC Hazen, CR Wolfe, EK Maziarz, JHoran, RD Davis, JM Reynolds, D
Anderson, DJ Sexton, LF Chen: A Cluster of Mycobacterium abscessus among Lung
Transplant Patients: Investigation and Mitigation; IDWeek, Oct 8, 2015, San Diego
R Bartz, J Hollingsworth, P Aguilar, K Klein, J Bohman, D Kor, H Babcock, D Schuller, B
Blough, A Swink, K Bartels, M Barron, A Babu, Lisa Boorman, M Cooter, M Daneshmand,
CR Wolfe, P Park: Outcomes of hospitalized influenza-positive patients at large
U.S.Extracorporaeal membrane oxygenation centers during 2013-2014 influenza season;
presented at American Thoracic Society 2015, Denver, May 2015
M Green, S Taranto, S Covington, M Michaels, C Wolfe, D Kaul; Pediatrics & Donor
Derived Disease Transmission: The US OPTN Experience; Oral Abstract, American
Transplant Congress; Philadelphia, May 6th, 2015
Epling C, Shulby G, Wolfe CR, Andolsek K; Transitioning Influenza Vaccination from a
Recommendation to a “Condition of Employmnt” for over 23,000 employees; presented at:
o NPSF Annual Patient Safety Congress, Austin, Tx, April 29, 2015
o International Forum on Quality and Safety in Health Care, April 24, 2015, London,
o DUHS Patient Safety Conference, Durham, March 2015
ME Clement, SG Norfolk, JM Reynolds, CR Wolfe, EKMaziarz: Prostate as Sanctuary Site:
Relapsed Blastomycosis in a Lung Transplant Recipient; International Society for Heart and
Lung Transplantation, Accepted for presentation - Nice, 2015. Abstract ID 2015-JF-2661-
ISHLT
Wolfe CR, Greenwald I, Thompson J; Telemedicine and its effects on disaster support team
member selection; International Conference on Emergency Medicine, June 2010, Abstract
ID : F-POS414/IT
Wolfe CR, Greenwald I, Thompson J; Academic medical centers and the creation of
international disaster support teams; International Conference on Emergency Medicine, June
2010, Abstract ID: T-POS191/DIS
Chen LF, Dailey NJ, Rao AK, Fleischauer AT, Greenwald I, Deyde VM, Moore ZS,
Anderson DJ, Duffy J, Gubareva LV, Sexton DJ, Fry AM, Srinivasan A, Wolfe CR; Cluster
of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Among
Immunocompromised Patients on a Hospital Ward — North Carolina; SHEA Decennial
International Conference on Healthcare-Associated Infections; March 2010, Abstract ID:
3013
C. Wolfe, D. Turner, C. Rudd, J. Pham, I. Cheifetz; Intravenous Zanamivir for Critical Illness
due to Pandemic H1N1 Influenza, SCCM, 40TH Critical Care Conference; Jan, 2011,
Abstract ID: 777
D.Kaul, C.Wolfe, et al; Time to Presentation of Donor Derived Infection; 2013 American
Transplant Congress, May 18, 2013; Abstract ID: B1038
CR Wolfe, C.Kotton, D.Kaul, M.Green, S.Taranto, M.Morris; Geographic variation in donor-
derived transplant infections; 2014 World Transplant Congress, Seattle, July, 2014
L.Porras, B.Boggess, CR Wolfe; Scarier than Acne: Chronic Shoulder Pain Caused By P.
Acnes Septic Arthritis; American Medical Society for Sports Medicine, 2014
M Green, S Covington, S Taranto, W Bell, SW Biggins, E Blumberg, G DeStafano, E
Dominguez, D Ennis, T Gross, M Klassen-Fischer, C Kotton, S Kusne, Y Law, M Menegus,
R Miller, M Pavlakas, T L Pruett, D LaPointe-Rudow, P Ruiz, N Siparsky, M Souter, L
Weiss, C Wolfe and D Kaul: Donor Derived Transmission Events in 2012: A Report of the
OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC); 2013 American
Transplant Congress, May 2013
S Kusne, S Taranto, S Convington, D Kaul … C Wolfe and M Green: Transmission of
Coccidioidomycosis through Organ Transplantation; oral abstract, 2013 American Transplant
Congress, May, 18, 2013
M Green, S Covington, S Taranto, …, C Wolfe and D Kaul: A report of the OPTN Ad Hoc
Disease Transmission Advisory Committee (DTAC); oral abstract, 2014 World Transplant
Congress, Seattle, July 2014,
BOOK CHAPTERS:
Wolfe CR and Visvanathan, K; Chapter - Rheumatic Fever , Infectious Diseases, Cohen,
Powderly, Opal et al, 3rd Edition, 2009 Elsevier
Wolfe CR; Identifying & managing casualties of biological terrorism; UpToDate, Edition
18.4, 2012.
NOTABLE ACHIEVEMENTS:
The London International Youth Science Forum, 1993; Australian Representative; including:
o Queen’s Trust Scholarship, 1993
Australia Day Young Citizen nominee; 1994
Team Leader; International Physics Olympiad, Canberra 1995; Canada 1997
Student representative and staff member, CRA National Youth Science Forum; 1993 -1995
EXTRA MEDICAL ACTIVITIES:
Conference Organizing Committee:
2010 SERCEB conference: Engaging Public Health, Academia and
Research in Pandemic Preparedness,
2010 SERCEB conference: Role of Academic Medical Centers in
international and local disaster relief,
2011 SERCEB conference: Examining the Role of Academic Consortia in
Epidemic Preparedness, Response, and Recovery – Cholera in Haiti
2012 SERCEB/SECEPT conference: Developing a Research and Education
Agenda for One Health,
Ad hoc Manuscript Reviewer:
o Blood, 2015- 2016
o Clinical Infectious Diseases, 2014-2016
o American Journal of Transplantation, 2012 – 2016
o Journal of Heart and Lung Transplantation, 2012 – 2016
o Transplant Infectious Diseases, 2014 - 2016
o BMC Infectious Diseases 2014 - 2015
o North Carolina Medical Journal 2014
o Oxford University Press – HIV publications, 2012 - 2013
o DovePress: HIV/AIDS - Research and Palliative Care, Neurobehavioral HIV
Medicine, 2010
Volunteer Physician, 2002:
East Timor: 13 weeks associated with Jesuit Refugee Service: Maliana
District Hospital, East Timor
Ethiopia: 8 weeks associated with Missionaries of Charity, Mother Theresa
Sisters: Hiv/A.I.D.S. Hospice, Addis Ababa; again, Oct 2012.
Rwanda: 8 weeks associated with World Vision, East Africa, Gahini
District Hospital
Kenya: 4 weeks associated with World Vision, East Africa, working in
Kibera, Nairobi.
Medical Electives,2000 – 3 months spent in:
Malawi: St John’s Hospital, Mzuzu– Medicine
Kenya: Kikuyu Hospital, Kikuyu– Orthopaedics, Trauma
Uganda: Kisiizi Hospital, Uganda– Medicine
Tutor: Pathology, Histology, Histopathology, Embryology, Queen’s College,
1999-2001, 2003
Melbourne University Rural and Remote Medicine Club (“Outlook”)
Vice-President, Secretary and Chairman; Queen’s College Sports & Social Club;
1996-1998 respectively
Queen’s College Council, Melbourne University, 1997
CURRENT & PREVIOUS FUNDING:
NIEHS, Grant Number: 1UH4ES027072-01
Ebola Biosafety and Infectious Disease Response Training
June 2016 – May 2019
Project Title: Duke Infectious Disease Response Training Consortium (DIDRT) Dr Wolfe is a co-Principal Investigator at the lead site, Duke University, working together
with faculty from the Duke Human Vaccine Institute and the Regional Biocontainment
Laboratory to create teaching and training modules for biosafety training specific to Ebola
virus and other novel emerging pathogens
NIAID, SSS CRB-DCR01-5-09-00318*
12/01/09 - 2013
Active
Influenza Research Collaborative Sites Combination Therapy Working Group Dr Wolfe is a representative of Duke University Health System providing leadership
regarding combination chemotherapeutic development for influenza.
Merck – MISP
02/01/12 – current
Active
Raltegravir Use in HIV patients receiving Solid Organ Transplantation
Dr Wolfe is the PI of a Duke University investigator-initiated, industry-funded study of
Raltegravir as an antiretroviral drug of choice for HIV patients with organ transplantation.
UNC – SERCEB, W00445725-30733
03/1/11 – 2014
Active
Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Dr Wolfe is an investigator on a regional biodefense and emerging infection grant centered at
University of North Carolina at Chapel Hill.
ACTG Adult AIDS Clinical Trials Unit (Thielman), NIH 5U01AI069484-04
12/06 - 2015
Active
To develop and implement hypothesis-driven, pathogenesis-based innovative clinical
trials for persons with HIV infection. Dr Wolfe is a co-investigator.
Glaxo Smith Kline – NAI 114373
10/18/10 – current
Active
Zanamivir for the treatment of severe influenza Dr Wolfe assists with statistics, safety and development of protocols for analysis of influenza
treatment options.
Research Grant – Roche
2011-2014
Active
Oseltamivir dosing for influenza in immunocompromised patients Dr Wolfe is a local PI at the Duke University site.
Research Grants – NIAID/Insight: FLU002, FLU003, FLU004, IRC003, FLU006-IVIG
2011- current
Active
Dosing and observational studies for influenza Dr Wolfe is a local PI at the Duke University site for five independently run NIH-funded
influenza studies observing treatment outcomes for high-risk outpatients and inpatients.
Research Grant – Ansun Biopharma
2013- current
Active
Use of DAS-181 for treat of Parainfluenza infection in immunocompromised patients
Dr Wolfe is a local PI at the Duke University site
SAMPLE MEDIA PRESENTATIONS:
Mary Brophy Marcus: Vaccine arrives as flu spreads; USA Today, Oct 6, 2010
o http://www.usatoday.com/news/health/2009-10-06-swine-flu-vaccine_N.htm
WRAL news, Oct 12, 2009 http://www.wral.com/news/local/video/6198033/
Sarah Avery: Duke concerned about drug resistant swine flu; The Charlotte Observer, Nov
21, 2009
o http://www.charlotteobserver.com/2009/11/21/1068072/duke-concerned-about-drug-
resistant.html
Radio: Here’s to your health: H1N1 influenza vaccination; 1360 WCHL, Feb 10, 2010;
The Herald Sun: Matthew Milliken: Duke medical team heading to Haiti; Feb 4, 2010
o http://www.heraldsun.com/view/full_story/5767274/article-Duke-medical-team-
heading-to-Haiti?instance=most_recommended
ABC 11 news: Duke doctors head to Haiti; Feb 4, 2010-08-1
o http://abclocal.go.com/wtvd/story?section=news/local&id=7257000
MedPage Today, Infectious Disease, West Nile Cost: $778 Million; Feb 10, 2014
o http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/44232
Radio WPTF-Talk Radio 850AM: http://www.wptf.com/ mp3 available upon request.
o Jan 6, 2014 Compare: Josh Zach, Topic: Infectious Disease Preparedness
o Jan 6, 2014 Compare: Josh Zach, Topic: Cold Temperatures and Flu Season
o Jan 7, 2014 Compare: Josh Zach, Topic: Duke Medicine restricts hospital visitation
o Feb 28, 2014 Compare: Brandon Dickson, Topic: Influenza mortality and spread
o Jan 29, 2016 Compare: Josh Zach, Topic: Zika virus infections and pregnancy
Forbes.com: David Knoll: More proof the flu vaccine works; Feb 16, 2014
o http://www.forbes.com/sites/davidkroll/2014/02/16/more-proof-the-flu-vaccine-
works/
US News & World Report: Flu hits unvaccinated hardest study finds; Feb 14, 2014
o http://health.usnews.com/health-news/articles/2014/02/14/flu-hits-unvaccinated-
hardest-study-finds
National Public Radio (NPR), Maanvi Singh: With this year’s flu young adults are not so
invincible; Feb 13, 2014
o http://www.npr.org/blogs/health/2014/02/12/276025918/with-this-years-flu-young-
adults-are-not-so-invincible
New York Times, Nicholas Bakalar: Young adults need flu shots too; Feb 12, 2014
o http://well.blogs.nytimes.com/2014/02/12/young-adults-need-flu-shots-
too/?_php=true&_type=blogs&_php=true&_type=blogs&_php=true&_type=blogs&
_php=true&_type=blogs&_php=true&_type=blogs&_php=true&_type=blogs&_r=5
Futurity, Monique Patenaude: Young adults who skip flu shot show most severe symptoms;
Feb 11, 2014
o http://www.futurity.org/young-unvaccinated-adults-account-severest-flu-cases/
The Herald-Sun, Keith Upchurch; Duke would be ready for Ebola case; Aug 14, 2014
o http://www.heraldsun.com/news/showcase/x571857220/Duke-would-be-ready-for-
Ebola-case
CBS News, ABC News, Marilynn Marchione; Zmapp cures monkeys of Ebola virus; Aug 29,
2014, Associated Press
o http://www.cbsnews.com/news/zmapp-cures-monkeys-of-ebola-virus/
o http://abcnews.go.com/Health/wireStory/experimental-ebola-drug-heals-monkeys-
study-25179843?singlePage=true
National Public Radio, Leoneda Inge, Is North Carolina Prepared for Ebola?; October 9,
2014, WUNC 91.5;
o http://wunc.org/post/north-carolina-prepared-ebola
The Conversation, Even with mismatches flu shots can keep you from getting sick. December
9, 2014
o https://theconversation.com/even-with-mismatches-flu-shots-can-still-keep-you-
from-getting-sick-35151
EverydayHealth.com, Jennifer Brown: 10 Essential Facts about Whooping Cough; published
2015-02-20
o http://www.everydayhealth.com/news/10-essential-facts-about-whooping-cough/
CBSNews.com, Ashley Welsh: Many Americans with HIV don't know they're infected; June
26, 2015
o http://www.cbsnews.com/news/many-americans-with-hiv-dont-know-theyre-
infected/
WNCN, Emma Wright; Duke specialist says Zika virus currently not a threat in the US, Jan
29th, 2016
o http://wncn.com/2016/01/29/duke-specialist-says-zika-virus-not-currently-a-threat-
in-us/
TimeWarnerCable News 14, Chris Williams; Duke Doctor: Zika vaccine is years away; Jan
29th, 2016
o http://www.twcnews.com/nc/triangle-sandhills/news/2016/01/29/duke-doctor--zika-
vaccine-is-years-away.html